Mersana Therapeutics Inc
MRSN
Market Cap$48.1M
Close$
$-1.14
414% downside
Current Fair Value
414% downsideOvervalued by 414% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $48.10 Million |
|---|---|
| Enterprise Value | $-9,379,897.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-0.56 |
| Beta | 0.82 |
| Outstanding Shares | 124,466,113 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.65 |
|---|---|
| PEG | -2.6 |
| Price to Sales | - |
| Price to Book Ratio | -0.36 |
| Enterprise Value to Revenue | -0.28 |
| Enterprise Value to EBIT | 0.15 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -4.78 |
| Debt to Equity | -1.45 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Mersana Therapeutics Inc
CEO: Anna Protopapas